Report Overview

The Global Mobile Gamma Cameras Market size is expected to be worth around US$ 91.8 Million by 2035 from US$ 56.9 Million in 2025, growing at a CAGR of 4.9% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 36.2% share with a revenue of US$ 20.6 Million.

The global Mobile Gamma Cameras Market is witnessing steady growth due to the increasing demand for portable nuclear imaging solutions across hospitals, diagnostic centers, and ambulatory care facilities. Mobile gamma cameras are specialized nuclear medicine imaging devices that detect gamma radiation emitted from radiopharmaceuticals administered to patients. These systems enable bedside and point-of-care imaging, reducing patient transportation and improving workflow efficiency in critical care settings.

The market is benefiting from the rising prevalence of cardiovascular diseases, cancer, neurological disorders, and kidney-related conditions that require functional imaging for diagnosis and treatment monitoring. Technological advancements such as compact detector systems, improved image resolution, wireless connectivity, and digital integration are enhancing the performance and usability of mobile gamma cameras.

Healthcare providers are increasingly adopting portable imaging equipment to support decentralized healthcare delivery and improve access to diagnostic services in remote and underserved areas. North America remains the leading regional market owing to advanced healthcare infrastructure and strong adoption of nuclear medicine technologies. Continued investments in healthcare modernization and growing awareness of early disease detection are expected to support long-term market expansion across developed and emerging economies

Click here for more information: https://market.us/report/global-mobile-gamma-cameras-market/

Key Takeaways

In 2025, the Mobile Gamma Cameras Market generated revenue of US$ 56.9 Million and is projected to reach US$ 91.8 Million by 2035, expanding at a CAGR of 4.9% during the forecast period.

Based on product type, the market is segmented into single head, double head, triple head, and hand-held gamma cameras. Among these, the single head segment dominated the market, accounting for 48.7% of the total market share in 2025.
By indication, the market is categorized into cardiac imaging, renal imaging, breast imaging, brain imaging, and others. The cardiac imaging segment emerged as the leading category, capturing 42.9% of the market share.

In terms of end users, the market is divided into hospitals, cancer research institutes, ambulatory surgical centers, and specialized clinics. The hospitals segment held the largest share, contributing 54.2% of the overall market revenue.

North America maintained its leadership position in the Mobile Gamma Cameras Market, accounting for 36.2% of the global market share in 2025.

Key Market Segments
By Product Type
Single Head
Triple Head
Double Head
Hand Held
By Indications
Cardiac Imaging
Renal Imaging
Breast Imaging
Brain Imaging
Others
By End Users
Hospitals
Cancer Research Institutes
Ambulatory Surgical Centers
Specialized Clinics

Market Key Players

GE HealthCare
Siemens Healthineers
Philips Healthcare
Digirad Corporation
DDD-Diagnostic A/S
Spectrum Dynamics Medical
Mediso Medical Imaging Systems
Neusoft Medical Systems
Crystal Photonics
Gamma Medica
Market Dynamics
Driver

One of the primary drivers of the Mobile Gamma Cameras Market is the increasing prevalence of chronic diseases requiring advanced diagnostic imaging. According to the World Health Organization (WHO), approximately 20 million new cancer cases and 9.7 million cancer-related deaths were reported globally in 2022. Cancer diagnosis and treatment monitoring frequently rely on nuclear medicine procedures, creating sustained demand for gamma camera technologies.

Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 17.9 million deaths annually according to WHO estimates. Mobile gamma cameras are widely used for myocardial perfusion imaging and other cardiac assessments that help physicians evaluate blood flow and heart function. Portable systems provide a significant advantage by allowing imaging at the bedside, particularly for critically ill patients.

In addition, aging populations are increasing the incidence of chronic disorders requiring repeated diagnostic evaluations. Hospitals are seeking flexible imaging solutions that improve workflow efficiency and patient convenience. As healthcare systems prioritize early diagnosis and precision medicine, demand for mobile gamma cameras is expected to rise steadily, supporting market growth throughout the forecast period.

Trend

A major trend shaping the Mobile Gamma Cameras Market is the growing adoption of portable and point-of-care diagnostic technologies. Healthcare providers increasingly prefer compact imaging systems that can be deployed in intensive care units, emergency departments, operating rooms, and outpatient facilities. Mobile gamma cameras enable functional imaging without requiring patients to be transported to dedicated nuclear medicine departments, improving clinical efficiency and patient safety.

Technological innovation is accelerating this trend. Manufacturers are developing lightweight systems with enhanced detector sensitivity, faster image acquisition, and improved digital connectivity. Integration with hospital information systems and imaging software allows clinicians to access diagnostic data more efficiently.

The International Atomic Energy Agency (IAEA) continues to document global growth in nuclear medicine infrastructure through its Nuclear Medicine Database, which tracks facilities, gamma cameras, and imaging procedures worldwide. As countries expand nuclear medicine services, demand for flexible imaging solutions is increasing.

Furthermore, healthcare systems are emphasizing decentralized care delivery models. Portable imaging technologies support this objective by extending advanced diagnostic capabilities beyond traditional hospital settings, making mobile gamma cameras an increasingly valuable component of modern healthcare infrastructure.

Restraint

Despite favorable growth prospects, the Mobile Gamma Cameras Market faces challenges associated with high acquisition and maintenance costs. Mobile gamma camera systems incorporate sophisticated detectors, advanced software platforms, radiation shielding components, and specialized engineering designed to maintain image quality in portable environments. These features significantly increase purchase prices compared with many conventional diagnostic devices.

Healthcare facilities must also account for ongoing expenses related to equipment calibration, service contracts, radiation safety compliance, and staff training. Smaller hospitals and community healthcare centers often face budget limitations that make investment in advanced nuclear imaging technologies difficult. Cost concerns are particularly evident in low- and middle-income countries where healthcare spending remains constrained.

In addition, nuclear medicine procedures require radiopharmaceuticals and trained specialists, increasing overall operational costs. Regulatory requirements governing radiation protection and equipment certification can further raise implementation expenses.

Although manufacturers are introducing compact and more efficient systems, affordability remains a key barrier to widespread adoption. Many healthcare providers continue to prioritize essential infrastructure investments over specialized imaging equipment. Consequently, financial constraints may slow purchasing decisions and limit market penetration, particularly in emerging healthcare markets.

Opportunity

The expansion of outpatient healthcare services presents a significant opportunity for the Mobile Gamma Cameras Market. Governments and healthcare organizations worldwide are promoting ambulatory and community-based care models to reduce hospital overcrowding and improve patient access to diagnostic services. Mobile gamma cameras are well suited for these settings because they offer flexibility, mobility, and efficient imaging capabilities without requiring extensive infrastructure.

Emerging economies across Asia-Pacific, Latin America, and the Middle East are investing heavily in healthcare modernization. Improvements in healthcare infrastructure, growing healthcare expenditures, and increasing awareness of early disease detection are supporting the adoption of advanced diagnostic technologies.

The International Atomic Energy Agency has highlighted the ongoing expansion of nuclear medicine facilities globally, creating opportunities for equipment suppliers to address unmet diagnostic needs.

Conclusion

The Mobile Gamma Cameras Market is poised for sustained growth as healthcare providers increasingly adopt portable diagnostic imaging solutions to improve efficiency, patient outcomes, and access to nuclear medicine services. Rising incidences of cancer, cardiovascular diseases, and other chronic conditions continue to drive demand for advanced imaging technologies. While high equipment and maintenance costs remain a challenge, ongoing technological advancements and expanding outpatient healthcare infrastructure are creating new growth opportunities. North America currently leads the market, but emerging economies are expected to contribute significantly to future expansion. With increasing emphasis on early diagnosis, decentralized healthcare delivery, and point-of-care imaging, mobile gamma cameras are expected to play a critical role in the future of diagnostic healthcare worldwide.